Detalhe da pesquisa
1.
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma.
Dig Dis Sci
; 62(3): 784-793, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28078526
2.
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
J Clin Gastroenterol
; 47(2): 130-5, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22647827
3.
Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
Ann Hepatol
; 12(2): 199-204, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23396730
4.
Antibodies to Mitotic Apparatus: New Association With Cholestatic Liver Disease.
Am J Gastroenterol
; 110(12): 1736-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26673508
5.
[Therapeutic update in hepatitis C]. / Actualización terapéutica en la hepatitis C.
Rev Esp Quimioter
; 28 Suppl 1: 48-51, 2015 Sep.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26365735
6.
Recurrence of Helicobacter pylori infection: 3650 patient-years follow-up study.
Helicobacter
; 13(5): 388, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19250514
7.
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
Am J Gastroenterol
; 103(1): 71-6, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17764498
8.
Chronic hepatitis C and autoimmune cholangitis: a case study and literature review.
Dig Dis Sci
; 47(6): 1224-9, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12064795
9.
Serum immunological profile in patients with chronic autoimmune cholestasis.
Am J Gastroenterol
; 99(11): 2150-7, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15554996